Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities.
Blood., Mar;119(11):2568-78 (2012)
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Blood., May;119(18):4123-8 (2012)
Lymphoma vaccine therapy: next steps after a positive, controlled phase III clinical trial.
Semin. Oncol., Jun;39(3):253-62 (2012)
Phase I Multidose-Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous Infusion Every 3 Weeks to Patients With Relapsed/Refractory B-Cell Lymphoma.
J. Clin. Oncol., Aug;30(22):2776-82 (2012)
Targeting cell surface Î²2 -microglobulin by pentameric IgM antibodies.
Br. J. Haematol., Jul;154(1):111-21 (2011)
Translational development of vaccination strategies in follicular NHL.
Best Pract Res Clin Haematol., Jun;24(2):295-304 (2011)
Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity.
Blood., Nov;114(19):4142-9 (2009)
Cancer vaccines: moving toward prevention?
Cancer Prev Res (Phila)., Jul;4(7):954-6 (2011)
Bortezomib-resistant nuclear factor ÎºB expression in stem-like cells in mantle cell lymphoma.
Exp. Hematol., Feb;40(2):107-18.e2 (2012)
Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.
Blood., Jan;119(1):161-9 (2012)
Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.
J. Mol. Med., Jun;90(6):695-706 (2012)
Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.
Vaccine., Nov;25(46):7955-61 (2007)
A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
J. Immunol. Methods., Feb;331(1-2):13-26 (2008)
Vaccine therapy for B-cell lymphomas: next-generation strategies.
Hematology Am Soc Hematol Educ Program., 243-9 (2007)
A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
Clin. Cancer Res., Apr;14(7):2154-60 (2008)
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Blood., Jun;111(12):5530-6 (2008)
Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth.
Cancer Res., Oct;68(20):8456-64 (2008)
Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma.
Clin. Cancer Res., Feb;15(3):951-9 (2009)
IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
Blood., Jul;114(2):360-70 (2009)
Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.
Blood., Oct;114(18):3880-9 (2009)